Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment: A Real-world Prospective Cohort Study

BACKGROUND: Patient-reported outcomes (PROs) can help to reduce uncertainties about hepatitis C virus (HCV) treatment with direct-acting antivirals (DAAs) among people who inject drugs and increase treatment uptake in this high-risk group. Besides clinical data, this study analyzed for the first tim...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulte, Bernd, Schmidt, Christiane S, Manthey, Jakob, Strada, Lisa, Christensen, Stefan, Cimander, Konrad, Görne, Herbert, Khaykin, Pavel, Scherbaum, Norbert, Walcher, Stefan, Mauss, Stefan, Schäfer, Ingo, Verthein, Uwe, Rehm, Jürgen, Reimer, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452367/
https://www.ncbi.nlm.nih.gov/pubmed/32875003
http://dx.doi.org/10.1093/ofid/ofaa317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452367/
https://www.ncbi.nlm.nih.gov/pubmed/32875003
http://dx.doi.org/10.1093/ofid/ofaa317

Ejemplares similares